Literature DB >> 206388

Cholinesterase in serum and low density lipoprotein of hyperlipidemic patients.

M I Chu, P Fontaine, K M Kutty, D Murphy, R Redheendran.   

Abstract

Cholinesterase activity in the low density lipoprotein fraction of serum is increased in types IIa, IIb and IV hyperlipoproteinemic patients, whereas only types IIb and IV show increases in serum cholinesterase activity. In obese patients, cholinesterase activity is increased both in the serum and low density lipoprotein fraction only when hyperlipidemia is present. Cholinesterase activity is also found to increase in proportion with increases in low density lipoprotein, cholesterol, and triglycerides both in the serum and low density lipoprotein fraction. We suggest on the basis of these findings that cholinesterase has a function in lipid and lipoprotein metabolism.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 206388     DOI: 10.1016/0009-8981(78)90100-6

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  9 in total

1.  A case of familial hyper-cholinesterasemia associated with isozyme variant band.

Authors:  K Yamamoto; F Morito; M Motomura; H Kaneoka; T Sakai
Journal:  Gastroenterol Jpn       Date:  1986-08

2.  Cholinesterase and paraoxonase (PON1) enzyme activities in Mexican-American mothers and children from an agricultural community.

Authors:  Veronica Gonzalez; Karen Huen; Subha Venkat; Kelly Pratt; Pin Xiang; Kim G Harley; Katherine Kogut; Celina M Trujillo; Asa Bradman; Brenda Eskenazi; Nina T Holland
Journal:  J Expo Sci Environ Epidemiol       Date:  2012-07-04       Impact factor: 5.563

3.  Abdominal Obesity Associated with Elevated Serum Butyrylcholinesterase Activity, Insulin Resistance and Reduced High Density Lipoprotein-Cholesterol Levels.

Authors:  Surapon Tangvarasittichai; Suthap Pongthaisong; Suwadee Meemark; Orathai Tangvarasittichai
Journal:  Indian J Clin Biochem       Date:  2014-06-01

4.  Characterization of serum cholinesterase in familial hyper-cholinesterasemia associated with an isozyme variant band.

Authors:  K Yamamoto; F Morito; Y Setoguchi; S Fujii; T Kariya; T Sakai
Journal:  Gastroenterol Jpn       Date:  1987-04

5.  Relationship between serum pseudocholinesterase and triglycerides in experimentally induced diabetes mellitus in rats.

Authors:  V Annapurna; I Senciall; A J Davis; K M Kutty
Journal:  Diabetologia       Date:  1991-05       Impact factor: 10.122

6.  Pseudocholinesterase in obesity: hypercaloric diet induced changes in experimental obese mice.

Authors:  K M Kutty; S N Huang; K T Kean
Journal:  Experientia       Date:  1981-11-15

7.  The effect of age and frailty upon blood esterase activities and their response to dietary supplementation.

Authors:  J Summerbell; H Wynne; C R Hankey; F M Williams
Journal:  Br J Clin Pharmacol       Date:  1993-11       Impact factor: 4.335

8.  Influence of Serum Cholinesterase Levels on Patients Suspected of Having Stable Coronary Artery Disease.

Authors:  Takahiro Mito; Masao Takemoto; Yoshibumi Antoku; Atsushi Tanaka; Atsutoshi Matsuo; Satoru Hida; Kiyonobu Yoshitake; Ken-Ichi Kosuga; Shin-Ichiro Miura
Journal:  Intern Med       Date:  2020-11-16       Impact factor: 1.271

9.  Butyrylcholinesterase as a prognostic marker: a review of the literature.

Authors:  Lidia Santarpia; Ilenia Grandone; Franco Contaldo; Fabrizio Pasanisi
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-09-06       Impact factor: 12.910

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.